74 related articles for article (PubMed ID: 9442397)
1. MHC class II deficiency: definition of a new complementation group.
Villard J; Mach B; Reith W
Immunobiology; 1997 Dec; 198(1-3):264-72. PubMed ID: 9442397
[TBL] [Abstract][Full Text] [Related]
2. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency.
Durand B; Sperisen P; Emery P; Barras E; Zufferey M; Mach B; Reith W
EMBO J; 1997 Mar; 16(5):1045-55. PubMed ID: 9118943
[TBL] [Abstract][Full Text] [Related]
3. Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency.
Villard J; Lisowska-Grospierre B; van den Elsen P; Fischer A; Reith W; Mach B
N Engl J Med; 1997 Sep; 337(11):748-53. PubMed ID: 9287230
[TBL] [Abstract][Full Text] [Related]
4. Genetic and molecular definition of complementation group D in MHC class II deficiency.
Fondaneche MC; Villard J; Wiszniewski W; Jouanguy E; Etzioni A; Le Deist F; Peijnenburg A; Casanova JL; Reith W; Mach B; Fischer A; Lisowska-Grospierre B
Hum Mol Genet; 1998 May; 7(5):879-85. PubMed ID: 9536093
[TBL] [Abstract][Full Text] [Related]
5. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome).
Steimle V; Otten LA; Zufferey M; Mach B
Cell; 1993 Oct; 75(1):135-46. PubMed ID: 8402893
[TBL] [Abstract][Full Text] [Related]
6. Conserved residues of the bare lymphocyte syndrome transcription factor RFXAP determine coordinate MHC class II expression.
Long AB; Ferguson AM; Majumder P; Nagarajan UM; Boss JM
Mol Immunol; 2006 Feb; 43(5):395-409. PubMed ID: 16337482
[TBL] [Abstract][Full Text] [Related]
7. Three novel mutations of the CIITA gene in MHC class II-deficient patients with a severe immunodeficiency.
Dziembowska M; Fondaneche MC; Vedrenne J; Barbieri G; Wiszniewski W; Picard C; Cant AJ; Steimle V; Charron D; Alca-Loridan C; Fischer A; Lisowska-Grospierre B
Immunogenetics; 2002 Feb; 53(10-11):821-9. PubMed ID: 11862382
[TBL] [Abstract][Full Text] [Related]
8. Genetic complexity of regulatory mutants defective for HLA class II gene expression.
Seidl C; Saraiya C; Osterweil Z; Fu YP; Lee JS
J Immunol; 1992 Mar; 148(5):1576-84. PubMed ID: 1538137
[TBL] [Abstract][Full Text] [Related]
9. Combined immunodeficiency with defective expression in MHC class II genes.
Griscelli C; Lisowska-Grospierre B; Mach B
Immunodefic Rev; 1989; 1(2):135-53. PubMed ID: 2517209
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional silencing of RFXAP in MHC class II-deficiency.
van Eggermond MC; Tezcan I; Heemskerk MH; van den Elsen PJ
Mol Immunol; 2008 May; 45(10):2920-8. PubMed ID: 18336911
[TBL] [Abstract][Full Text] [Related]
11. MHC class I and II deficiencies.
Hanna S; Etzioni A
J Allergy Clin Immunol; 2014 Aug; 134(2):269-75. PubMed ID: 25001848
[TBL] [Abstract][Full Text] [Related]
12. Correction of defective expression in MHC class II deficiency (bare lymphocyte syndrome) cells by retroviral transduction of CIITA.
Bradley MB; Fernandez JM; Ungers G; Diaz-Barrientos T; Steimle V; Mach B; O'Reilly R; Lee JS
J Immunol; 1997 Aug; 159(3):1086-95. PubMed ID: 9233601
[TBL] [Abstract][Full Text] [Related]
13. Analysis of mutations and chromosomal localisation of the gene encoding RFX5, a novel transcription factor affected in major histocompatibility complex class II deficiency.
Villard J; Reith W; Barras E; Gos A; Morris MA; Antonarakis SE; Van den Elsen PJ; Mach B
Hum Mutat; 1997; 10(6):430-5. PubMed ID: 9401005
[TBL] [Abstract][Full Text] [Related]
14. Two newly diagnosed HLA class II-deficient patients identified by rapid vector-based complementation analysis reveal discoordinate invariant chain expression levels.
Schmetterer KG; Seidel MG; Körmöczi U; Rottal A; Schwarz K; Matthes-Martin S; Steinberger P; Pickl WF
Int Arch Allergy Immunol; 2010; 152(4):390-400. PubMed ID: 20197681
[TBL] [Abstract][Full Text] [Related]
15. Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II-deficient patients belonging to complementation group B.
Wiszniewski W; Fondaneche MC; Lambert N; Masternak K; Picard C; Notarangelo L; Schwartz K; Bal J; Reith W; Alcaide C; de Saint Basile G; Fischer A; Lisowska-Grospierre B
Immunogenetics; 2000 Apr; 51(4-5):261-7. PubMed ID: 10803838
[TBL] [Abstract][Full Text] [Related]
16. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome).
Steimle V; Durand B; Barras E; Zufferey M; Hadam MR; Mach B; Reith W
Genes Dev; 1995 May; 9(9):1021-32. PubMed ID: 7744245
[TBL] [Abstract][Full Text] [Related]
17. Complex regulation of class II gene expression: analysis with class II mutant cell lines.
Glimcher LH; McKean DJ; Choi E; Seidman JG
J Immunol; 1985 Nov; 135(5):3542-50. PubMed ID: 2995495
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional control of MHC genes and T cell development in MHC class II deficiency.
Godthelp B; Van Eggermond MC; Gobin SJ; Van den Elsen PJ
Arch Immunol Ther Exp (Warsz); 1999; 47(6):341-6. PubMed ID: 10608289
[TBL] [Abstract][Full Text] [Related]
19. Regulation of MHC class II expression, a unique regulatory system identified by the study of a primary immunodeficiency disease.
Krawczyk M; Reith W
Tissue Antigens; 2006 Mar; 67(3):183-97. PubMed ID: 16573555
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of IL-10 protein synthesis induces major histocompatibility complex class II gene expression in class II-deficient patients.
Hauber I; Wolf HM; Samstag A; Pein B; Kreil TR; Gulle H; Fischer MB; Eibl MM
Cell Immunol; 1997 Sep; 180(2):95-103. PubMed ID: 9341739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
